HOME >> MEDICINE >> NEWS
High cholesterol and calcification are to blame for aortic valve disease

(CHICAGO) High cholesterol levels can lead to fatty deposits in the aortic valve. These deposits may induce undifferentiated cells to transform to bone-forming cells that calcify and narrow the aortic valve, according to researchers. Narrowing of the aortic valve is a common condition that causes the heart to have to squeeze harder to support normal blood flow, causing the heart muscle to enlarge and eventually fail. A study published today in Circulation authored by researchers at Northwestern and the Mayo Clinic is the first to explain the mechanism responsible for this process.

Aortic valvular disease is the most common reason for surgical valve replacement. No medical therapy has been proven to alter the progression of aortic valve disease. We conducted a test on laboratory model of aortic stenosis to determine whether high cholesterol led to the fatty deposits and resulting bone formation in the aortic valve and whether this progression could be controlled with the use of statins, explains lead author Nalini Rajamannan, MD, cardiologist, Northwestern Memorial Hospital and assistant professor of cardiology, The Feinberg School of Medicine at Northwestern University.

Our lab studies showed that statins greatly reduced the prevalence of the bone-forming cells and reduced the extent of changes in the aortic valve, said Dr. Rajamannan. Our findings, combined with recent retrospective clinical studies that showed that statins in patients slowed the rate of progression for aortic valve disease, point to possible benefits of using statins to treat patients with early stages of the aortic valve disease process. Earlier statin use may prolong the time to severe disease and the need for surgical valve replacement. Statins are drugs that block the formation of cholesterol in the liver and increase the production of the receptors on liver cells that clean the bad cholesterol from the blood.

We need to do large randomized trials using stat
'"/>

Contact: Amanda Widtfeldt
awidtfel@nmh.org
312-926-2955
Northwestern Memorial Hospital
3-Jun-2002


Page: 1 2

Related medicine news :

1. Boston University team finds link between high cholesterol and better cognitive performance
2. Decreased levels of good cholesterol in children with Progeria may cause premature heart disease
3. McGill researchers identify new way to reduce cholesterol levels
4. Researcher breaks down cholesterol mystery
5. American ethnic groups less likely to have cholesterol controlled
6. New Crestor data in African-American patients with high cholesterol
7. Nevirapine is better than efavirenz at raising good cholesterol
8. New way of controlling cholesterol may help treat Alzheimers
9. MRI can measure early benefits of cholesterol-lowering drugs and plaque reduction
10. Study supports aggressive treatment of heart patients with cholesterol-lowering medication
11. Blueberry compound shows promise of lowering cholesterol as effectively as drug

Post Your Comments:
(Date:5/24/2015)... Metamora, Michigan (PRWEB) May 24, 2015 ... for concerns about hair loss. Although it is unclear ... that there are environmental factors such as metabolism, nutritional ... contribute. Since they offer a comprehensive approach to evaluating ... and post-menopausal woman, they can help patients find a ...
(Date:5/24/2015)... Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... tests, which will allow them to take pressure measurements ... about bladder function. The doctor usually orders it if ... or overactive bladder (OAB). , Women’s Excellence ... that have problems with unwanted urinary leakage or problems ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 EnviroLeather™ ... launches “InkGard™ Plus” – a classic, rugged leather ... polymer allowing difficult stains, including ink, to be ... different colors suitable for corporate, healthcare, hospitality and ... line with EnviroLeather’s goal of developing products that ...
(Date:5/24/2015)... Viejo, CA (PRWEB) May 24, 2015 ProPin ... use in Final Cut Pro X. Utilize ProPin to pin ... in a given scene. , ProPin allows users to ... completely customizable in FCPX. With on-screen controls, video editors can ... allows users to pin and mark with absolute ease. , Using ...
(Date:5/24/2015)... 2015 Medicx Media Solutions ... executive Jay Krihak as its head of programmatic ... up its expertise and leadership position in the ... Health sectors. , Krihak is an experienced, award-winning ... Krihak led sales planning teams for mobile platform ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Medicx Media Solutions Expands Executive Team 2
(Date:5/22/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... the results of the Company,s 72-patient, placebo-controlled Phase ... for the treatment of dry eye patients using ... model.  The exploratory study was completed in late ... by the Company in a press release, identify ...
(Date:5/22/2015)... 20, 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ... "Guide to Prepare Application Dossiers for Oversea Medical ... " report to their offering. ... segment market of the most growth potentiality, which ... manufacturers and producers to penetrate such market. It ...
(Date:5/22/2015)... 2015 Today, Rhodes Pharmaceuticals L.P. announced that ... indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) ... The announcement comes just one ... U.S. Food and Drug Administration (FDA). ... methylphenidate capsule with an onset of effect of ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
Cached News: